Claire Chewapreecha, Simon R. Harris, Nicholas J. Croucher, Claudia Turner, Pekka Marttinen, Lei Cheng, Alberto Pessia, David M. Aanensen, S Salt- Er, Alison E. Mather, Andrew J. Page, David Harris, François Nosten, David Goldblatt, Jukka Corander, Julian Parkhill, Paul Turner, Stephen D. Bentley, Bhim Gopal Dhoubhadel, Lay‐Myint Yoshida, Hanh T. H. Nguyen, Le Huu Nhat Minh, Huong Thi Le, Michio Yasunami, Motoi Suzuki, Konosuke Morimoto, Dinh Kha Dang, Koya Ariyoshi, Adam Finn, Emily Nicoli, Begonia Morales‐Aza, Robert E. Holland, Luís Januário, Barry Vipond, Peter Muir, Fernanda Rodrigues, Erida Gjini, Carina Valente, Raquel Sá‐Leão, Geovana Oliveira Gomes, Carlos G. Grijalva, Marie R. Griffin, Kathryn M. Edwards, John V. Williams, Ana M. Gil, Héctor Verástegui, Stella M. Hartinger, Jorge E. Vidal, Keith P. Klugman, Claudio F. Lanata, Rama Kandasamy, Meeru Gurung, Susan Ndimah, Ajit Thapa, N Adiakhari, David R. Murdoch, Dominic F. Kelly, Shrijana Shrestha, Stephen Thorson, Jason Hinds, Andrew J. Pollard, Olivier le Polain de Waroux, Stefan Flasche, David Prieto‐Merino, W. John EdmundsPneumonia2014 · DOI
Homologous recombination is a primary evolutionary force for Streptococcus pneumoniae, enabling the introduction of genetic material that confers selective advantages during carriage—the asymptomatic colonization of the human nasopharynx and a prerequisite for invasive disease. This paper synthesizes findings from the 9th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-9), including a high-resolution genomic study of 3,085 isolates from a Thai refugee camp. Results highlight consistent recombination "hotspots" across lineages, often associated with drug resistance and shifting antibiotic consumption. Furthermore, we explore how pneumococcal conjugate vaccines (PCVs) and the nasopharyngeal microbiome reshape colonization dynamics, emphasizing the role of viral co-infections in facilitating acquisition.
Introduction
While vaccines effectively target S. pneumoniae, the bacteria's adaptive capacity remains a significant challenge. Carriage serves as the reservoir for outbreaks of pneumonia, meningitis, and sepsis. Understanding the dynamics of colonization—including strain competition, vaccine-induced serotype replacement, and microbiome interactions—is critical for designing future intervention strategies.
Genomic Evolution and Recombination
High-density sampling and whole-genome sequencing (WGS) have revealed the impact of recombination on pneumococcal evolution. In a longitudinal study of a Thai refugee camp, researchers identified recombination hotspots that facilitate adaptation to selective pressures, such as antibiotic use. Notably, non-encapsulated lineages exhibited the highest frequencies of DNA exchange, suggesting these non-vaccine target lineages play a pivotal role in the population's overall diversification and adaptation.
The Impact of Vaccination and Serotype Replacement
A recurring theme in recent research is "serotype replacement." As PCVs eliminate target strains (e.g., 19F), non-vaccine strains (e.g., 19A or 6C) rapidly fill the vacated niche. In American Indian communities, the introduction of PCV13 reduced vaccine-type colonization from 12% to 4% within two years, yet the long-term clinical impact of the emerging replacement strains remains a subject of intense study.
Microbial and Viral Interactions
The nasopharyngeal microbiome acts as a gatekeeper for colonization. The presence of commensals like Corynebacterium spp. is associated with a lower risk of pneumococcal carriage. Conversely, respiratory viral infections significantly alter the risk profile for bacterial acquisition.
Viral Facilitation of Colonization
One of the most striking findings is the synergy between viruses and bacteria. Data indicates that specific viral infections, particularly influenza and parainfluenza (PIV), significantly increase the odds of acquiring new pneumococcal strains.
Adjusted odds ratio (95% CI) for pneumococcal acquisition following various respiratory infections. Influenza and Parainfluenza (PIV) show the strongest positive associations with new acquisition.
The complexity of pneumococcal carriage—characterized by frequent multi-strain colonization and rapid genetic adaptation—necessitates a move toward high-resolution molecular surveillance. Future strategies may need to look beyond the polysaccharide capsule toward protein-based vaccines to provide broader protection against this highly recombinogenic pathogen.
Summary updated
Abstract
Homologous recombination is one of the main evolutionary forces affecting Streptococcus pneumoniae. The highly recombinogenic nature of this species allows introduction of genetic material with selective advantages in carriage, the state that is a prerequisite for the development of pneumococcal invasive diseases. To study the impact of recombination on the evolution of a carriage pneumococcal population, whole genome sequencing was used to characterize 3,085 pneumococcal carriage isolates from a 2.4 km 2 Thai refugee camp collected over a 3-year period. This high sampling density allowed us to characterized genetic exchanges in the pneumococcal population at a high resolution. Recombination 'hotspots' showed remarkable consistency between lineages, some of which were associated with drug resistance. Temporal trends in recombination at these sites reflected changes in antibiotic consumption, suggesting recombination facilitates adaptation to changing selection pressures. The highest frequencies of receipt and donation of DNA fragments exchanged through homologous recombination were observed in non-encapsulated lineages, implying a potential role in diversification and adaptation of the overall population played by these non-vaccine target lineages. These findings expand our understanding of pneumococcal population in carriage and help inform the design of future intervention strategies.
BibTeX
@inproceedings{chewapreecha2014pneumococcal,
author = {Claire Chewapreecha and Simon R. Harris and Nicholas J. Croucher and Claudia Turner and Pekka Marttinen and Lei Cheng and Alberto Pessia and David M. Aanensen and S Salt- Er and Alison E. Mather and Andrew J. Page and David Harris and François Nosten and David Goldblatt and Jukka Corander and Julian Parkhill and Paul Turner and Stephen D. Bentley and Bhim Gopal Dhoubhadel and Lay‐Myint Yoshida and Hanh T. H. Nguyen and Le Huu Nhat Minh and Huong Thi Le and Michio Yasunami and Motoi Suzuki and Konosuke Morimoto and Dinh Kha Dang and Koya Ariyoshi and Adam Finn and Emily Nicoli and Begonia Morales‐Aza and Robert E. Holland and Luís Januário and Barry Vipond and Peter Muir and Fernanda Rodrigues and Erida Gjini and Carina Valente and Raquel Sá‐Leão and Geovana Oliveira Gomes and Carlos G. Grijalva and Marie R. Griffin and Kathryn M. Edwards and John V. Williams and Ana M. Gil and Héctor Verástegui and Stella M. Hartinger and Jorge E. Vidal and Keith P. Klugman and Claudio F. Lanata and Rama Kandasamy and Meeru Gurung and Susan Ndimah and Ajit Thapa and N Adiakhari and David R. Murdoch and Dominic F. Kelly and Shrijana Shrestha and Stephen Thorson and Jason Hinds and Andrew J. Pollard and Olivier le Polain de Waroux and Stefan Flasche and David Prieto‐Merino and W. John Edmunds and W Edmunds},
title = {{Pneumococcal colonization and carriage}},
booktitle = {Pneumonia},
year = {2014},
doi = {10.1007/bf03399438},
}